Table 3.
Study | Incomplete outcome data addressed? | Free of selective reporting | Free of other bias? | Baseline outcomes similar? | Free of contamination? | Baseline characteristics similar? |
---|---|---|---|---|---|---|
Zhu30 | Unclear risk | Low risk | Low risk | Unclear risk | Low risk | Unclear risk |
Deorari33 | Unclear risk | Low risk | Low risk | Unclear risk | Low risk | Unclear risk |
Jeffery22 | Unclear risk | Low risk | Low risk | Unclear risk | Unclear risk | Unclear risk |
Vakrilova31 | Low risk | Low risk | High risk | Unclear risk | High risk | Unclear risk |
O’Hare23 | Low risk | Low risk | Unclear risk | Unclear risk | Low risk | Unclear risk |
Opiyo24 | Unclear risk | Low risk | Unclear risk | Unclear risk | Low risk | Unclear risk |
Boo25 | Low risk | Low risk | Unclear risk | Unclear risk | High risk | Low risk |
Hole35 | High risk | Low risk | Unclear risk | Unclear risk | High risk | Unclear risk |
Sorenson26 | Low risk | Low risk | Low risk | Unclear risk | Low risk | Low risk |
Patel 12 | Low risk | Low risk | Unclear risk | Unclear risk | Low risk | Low risk |
Msemo28 | Unclear risk | Low risk | Low risk | Unclear risk | Low risk | Unclear risk |
Bellad29 | Low risk | Low risk | Low risk | Unclear risk | Low risk | High risk |
Ashish12 | Low risk | Low risk | Low risk | Unclear risk | Low risk | High risk |
Goudar27 | Unclear risk | Low risk | Unclear risk | Unclear risk | Low risk | Low risk |
Risk of Bias assessed using the criteria suggested by Cochrane Effective Practice and Organization of Care19and criteria outlined in Chapter 8 of Cochrane Handbook for Systematic Reviews and interventions.